1. 1. S Fishbane, and J Berns . Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin . 2005 ; 68 : 1337 -43 .
2. 2. KM Bannister, and P Snelling . National haemodialysis guidelines: An assessment of compliance from 2001 to 2003 . 2006 ; 11 : 90 -6 .
3. 3. C Pollock, L Barratt, D Saltissi, J Knight, and D Vimalachandra et al.In: The CARI Guidelines. (eds). Biochemical and haematological targets . Haemoglobin.Guideline 8, p. 27. Excerpta Medica Communications, Chatswood2000 .
4. 4. National Kidney Foundation., NKF-DOQI clinical practice guidelines for anemia of chronic kidney disease: Update 2000 . 2001 ; 37 : S182 -238 .
5. 5. IC Macdougall . Optimizing the use of erythropoietic agents - pharmacokinetic and pharmacodynamic considerations . 2002 ; 17 : 66 -70 .